Ed NFkB (@edikb) profile picture

Ed NFkB

@edikb
 Charlottesville, VA
Joined June 2010
  • Tweets119
  • Following219
  • Followers47
7Media
Photo by Ed NFkB (@edikb)Photo by Ed NFkB (@edikb)Photo by Ed NFkB (@edikb)Photo by Ed NFkB (@edikb)Photo by Ed NFkB (@edikb)Photo by Ed NFkB (@edikb)Photo by Ed NFkB (@edikb)
.@YehlabUNC presenting @PanCAN Know Your Tumor data from @MPishvaian showing survival benefit of #pancreaticcancer patients receiving #precisionmedicine matched therapy. #AACRpan22
Image from Allison Rosenzweig (@arosenzweig19)
1
6
1
29
Dr Thomas Seufferlein of @UniklinikUlm shows promising data that there could be hidden subpopulations that when matched with targeted therapy may impact treatment outcomes in #pancsm #GIonc #ASCO22
Image from Dr Joseph McCollom DO (@realbowtiedoc)
2
1
3
📢In preparation for #ASCO22, I wanted to present my list for the #PancreaticCancer abstracts to👀for @ASCO Again,🙏note - I went through a LOT of abstracts, and I definitely may have missed some‼️ 👉And these are not in any particular order ✅But enjoy, RT, and reply😀
4
29
6
116
It was?? That's AWESOME‼️😃🎉 🙏so much @CDebyaniPhD for 👉this Huge CONGRATS for SUCH a TEAM🏅effort @DrHendifar @edikb @Perthera Brian Wolpin @VivekSubbiah Erik Collisson Isha Singh Tim Cannon @kennamshaw Chip Petricoin @KlempnerSam @EmilyLyons87 @WangGillam @EileenMOReilly
Debyani Chakravarty, PhD 🇺🇦 (@CDebyaniPhD) profile pictureDebyani Chakravarty, PhD 🇺🇦@CDebyaniPhD13 Dec 2021
Congrats @EileenMOReilly @MPishvaian @DrHendifar & Edik Blais for their impt article re RAS family alterations in #PancreaticCancer & their real world outcomes in resp to MAPK pathway inhibitors. Most downloaded @JCOPO_ASCO article in 2021! bit.ly/3ES375x Into OncoKB!
Image from Debyani Chakravarty, PhD 🇺🇦 (@CDebyaniPhD)
Image from Debyani Chakravarty, PhD 🇺🇦 (@CDebyaniPhD)
8
24
"Because the alterations are so rare, 1 single institution wouldn’t be able to draw conclusions about the best treatment approaches" @EmilyLyons87 @PanCAN - wonderful example of collaboration for the benefit of #pancreaticcancer patients! 💜
PanCAN (@PanCAN) profile picturePanCAN
@PanCAN25 Aug 2021
We're excited to announce a paper published today in @ASCO_Pubs #JCOPO that looks at the outcomes of #pancreaticcancer patients with alterations to the RAF gene and treatment targeted to that genetic alteration. Learn more at pcan.at/3x729b
New Study Describes Treatment Approach for a Subset of Pancreatic Cancer Patients

New Study Describes Treatment Approach for a Subset of Pancreatic Cancer Patients

Pancreatic cancer patients whose treatment matches their biology can live longer. PanCAN and partners published a study providing clinical outcomes for patients with tumors with RAF alterations.

pancan.org
1
5
15
Ed NFkB retweeted
PanCAN (@PanCAN) profile picture
PanCAN
@PanCAN25 Aug 2021
Replying to @PanCAN @ASCO_pubs
Amazing collaboration w/ @DrHendifar @CSCancerCare @edikb @MPishvaian @Perthera @DanaFarber @VivekSubbiah @kennamshaw @MDAndersonNews @UCSFCancer @EileenMOReilly @sloan_kettering @GeorgeMasonU @WUSTLmed @hopkinskimmel @EmilyLyons87 @PanCAN
5
11
Ed NFkB retweeted
PanCAN (@PanCAN) profile picture
PanCAN
@PanCAN25 Aug 2021
We're excited to announce a paper published today in @ASCO_Pubs #JCOPO that looks at the outcomes of #pancreaticcancer patients with alterations to the RAF gene and treatment targeted to that genetic alteration. Learn more at pcan.at/3x729b
New Study Describes Treatment Approach for a Subset of Pancreatic Cancer Patients

New Study Describes Treatment Approach for a Subset of Pancreatic Cancer Patients

Pancreatic cancer patients whose treatment matches their biology can live longer. PanCAN and partners published a study providing clinical outcomes for patients with tumors with RAF alterations.

pancan.org
1
9
1
18
🚨Hot off the press 👉Analysis of RAF Family Alterations in Pancreatic Cancer: Real-World Outcomes. Kudos to @PanCAN team @EmilyLyons87 @arosenzweig19 @DrHendifar @MPishvaian @kennamshaw et al for the collaboration & perseverance @ASCO_pubs bit.ly/3kvNg3E
Image from Vivek Subbiah, MD (@VivekSubbiah)
Image from Vivek Subbiah, MD (@VivekSubbiah)
Image from Vivek Subbiah, MD (@VivekSubbiah)
Image from Vivek Subbiah, MD (@VivekSubbiah)
2
24
43
#PrecisionMedicine 🚨 in #pancreaticcancer @PanCAN @lustgartenfdn @paNCfoundation Lead @MPishvaian and Andrew Hendifar through @accru__network @MayoCancerCare Binimetinib & Encorafenib in Pancreatic Cancer in tumors With a Somatic #BRAFV600E Mutation clinicaltrials.gov/ct2/show/…
8
21
Dear Colleagues at #ASCO20 A great pleasure to present OUR TOP #OncoAlert 🚨abstracts as picked by our expert colleague @MPishvaian Hope they help everyone navigate the meeting in terms of #GI #Cancers #CRCSM #colorectalcancer #Cholangiocarcinoma Best @weoncologists
Image from OncoAlert (@OncoAlert)
6
1
14
Our #ASCO20 #RealWorldEvidence poster on #KRAS variants in pancreatic cancer is now online! Novel association between KRAS Q61 & shorter PFS on FOLFIRINOX being explored with @DrHendifar @MPishvaian #pancsm perthera.com/asco20/
Image from Perthera (@Perthera)
Image from Perthera (@Perthera)
Image from Perthera (@Perthera)
9
1
16
Our #CGP analysis @DrHendifar of #KRAS variants and their prognostic/predictive implications in #pancsm including poorly described #KRASQ61 #KRASWT tumors also w/actionable targets poster tomorrow 5/29/20 collab w/@Perthera @PanCAN @CSCancerCare meetinglibrary.asco.org/reco… – at Los Angeles, CA
Image from Jun Gong, MD (@jgong15)
7
10
Ed NFkB retweeted
PanCAN (@PanCAN) profile picture
PanCAN
@PanCAN3 Apr 2020
.@PanCAN’s chief science officer, @LynnMatrisian, sits down with @LetsWinpc to discuss the exciting study published in @TheLancet Oncology earlier this year on molecular profiling for #pancreaticcancer patients. letswinpc.org/promising-scie…
7
1
16
Thanks to @MPishvaian and @PanCAN and KYT program!
Alan Burguete-Torres M.D. (@dralanburguete) profile pictureAlan Burguete-Torres M.D.@dralanburguete31 Mar 2020
I had to borrow your slide Professor @EileenMOReilly, to show it to my Med Onc residents in e-class and stress the importance of mutation analysis of PDAC.
Image from Alan Burguete-Torres M.D. (@dralanburguete)
1
6
1
27
Genetically targeted therapy significantly extended survival for patients with pancreatic cancer compared with standard chemo, according to study in @TheLancetOncol let by Michael Pishvaian MD @MPishvaian @hopkinskimmel bit.ly/38nZOlp #PrecisionMedicine
Image from HemOnc Today (@HemOncToday)
4
3
New research reveals #PancreaticCancer patients who receive precision medicine live an average of one year longer than those who do not. @MPishvaian @Perthera @PanCAN bit.ly/39wvir3
3
6
Congrats to @PanCAN on the great results in advanced #PancreaticCancer Overall survival in patients with pancreatic cancer receiving matched therapies following molecular profiling: a retrospective analysis of the Know Your Tumor registry trial thelancet.com/journals/lanon…
34
4
87
Ed NFkB retweeted
PanCAN (@PanCAN) profile picture
PanCAN
@PanCAN3 Mar 2020
Thank you @NCIDirector, this is a huge breakthrough for the #pancreaticcancer community! We will continue the hard work for our patients.
Dr. Anthony Letai (@NCIDirector) profile pictureDr. Anthony Letai@NCIDirector3 Mar 2020
Congrats to @PanCAN on the great results in advanced #PancreaticCancer Overall survival in patients with pancreatic cancer receiving matched therapies following molecular profiling: a retrospective analysis of the Know Your Tumor registry trial thelancet.com/journals/lanon…
6
2
23
Ed NFkB retweeted
Perthera (@Perthera) profile picture
Perthera@Perthera3 Mar 2020
Check out our latest study published in @TheLancetOncol demonstrating the real-world impact of #PrecisionOncology in #PancreaticCancer! Results showed a 1 year overall survival benefit. Thanks to the patients who participated, their doctors, and @PanCAN perthera.com/wp-content/uplo…
4
9
Great to hear that this patient was able to select a targeted therapy clinical trial as a result of participation in @PanCAN's #KnowYourTumor service! Wonderful story to end #pancreaticcancer #clinicaltrials awareness month!
PanCAN (@PanCAN) profile picturePanCAN
@PanCAN28 Jan 2020
When Gina Harrison's precision medicine report showed a BRCA mutation, we provided her a list of clinical trials. Now, she's starting an investigational treatment combining targeted therapy and immunotherapy. Read how Gina found the right trial for her. pcan.at/xqgtme
2
6
Load more